Garvey LJ, Smith CJ, Stingone C, et al. Fall in HCV incidence in hiv+MSM in London following wider access to DAA therapy. CROI 2019, abstract 85.
Veiligheid en immunogeniciteit van 1 versus 2 doses tetravalent denguevaccin
sep 2017 | Virale infecties